Molecular Mechanisms of Human Liver Diseases 2.0
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 6444
Special Issue Editor
Special Issue Information
Dear Colleagues,
There are many known liver diseases, the most prominent of which are virus-induced and autoimmune hepatitis, non-alcoholic fatty liver disease (NAFLD), storage diseases such as Wilson’s disease and hemochromatosis, and acute and chronic liver failure.
NAFLD, which includes steatohepatitis (in particular, non-alcoholic steatohepatitis (NASH), which should be separated from alcoholic steatohepatitis (ASH)) and steatosis, is a rising health problem world-wide. Steatosis, liver fibrosis, and cirrhosis often develop into hepatocellular carcinogenesis, frequently resulting in the need for liver transplantation, which underlines the clinical significance of this disease complex.
Wilson’s disease (which involves morbidly heightened copper accumulation) and hemochromatosis can also both result in cirrhosis. Whereas acute liver failure can have multiple origins over a short period of time, chronic liver failure is preceded by HBV, HCV, or excessive alcohol intake over a long time span.
In this Special Issue, we provide an overview of current knowledge and recent findings regarding the development, progression, molecular pathways, and mechanisms of these diseases.
Dr. Elena Grossini
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- non-alcoholic fatty liver disease (NAFLD)
- non-alcoholic steatohepatitis (NASH)
- alcoholic steatohepatitis (ASH) Wilson’s disease
- hemochromatosis
- viral hepatitis
- autoimmune hepatitis
- hepatocellular carcinoma
- signaling pathways
- molecular mechanisms